References
- Lydecken K. Therapeutic amenorrhea induced with lynestrenol in mentally retarded. Acta Psychiatr Scand 1972; 229: 7–67, Suppl
- Huovinen K, Autio S, Kaprio J. Peroral Iynestrenol and arterial disease in mentally retarded women: a case control study based on autopsy findings. Acta Obstet Gynecol Scand 1988; 67: 211–4
- Kay C. Present perspectives and clinical implications. In: The Pill in Perspective. J Obstet Gynecol 1984; 4: 98–102
- Yasuda J, Honjo H, Okada H. Metabolism of Iynestrenol: Characterization of 3-hydroxylation using rabbit liver microsomes in vitro. J Steroidal Biochem 1984; 21: 777–80
- Tikkanen M J, Kuusi T, Nikkilä E A, Sipinen S. Postmenopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review. Maturitas 1986; 8: 7–17
- Huovinen K, Tikkanen M J, Varonen S, et al. The effect of peroral Iynestrenol on serum lipids and lipoproteins in therapeutic amenorrhea of mentally retarded women. Acta Obstet Gynecol Scand 1990; 69: 35–10
- Gordon T, Castelli W, Hjortland M, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–14
- Levy R. Cholesterol, lipoproteins, apoproteins and heart disease: Present status and future prospects. Clin Chem 1981; 27: 653–62
- Maciejko J, Holmes D, Kottke B, et al. Apoprotein Al as a marker of angiographically assessed coronary artery disease. N Engl J Med 1983; 309: 285–9
- Frank P. Progestogens, lipoproteins, and arterial disease. Evidence from the study of Royal College of General Practitioners. Oral Contraceptives and Lipoproteins, P A Van Keep, H Kopera. International Health Foundation, Geneva 1983; 44–5
- Gunnig G, Moyer D. The effect of medroxyprogesterone acetate on endometriosis in the human female. Fertil Steril 1967; 18: 759–74
- Tikkanen M J, Nikkilä E A, Kuusi T, Sipinen S. Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. Atherosclerosis 1981; 40: 365–9
- Friedewald W, Lewy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 118: 499–502
- Wieland H, Siedel D. A simple specific method for precipitation low density lipoproteins. J Lipid Res 1983; 24: 904
- Frick M H, Elo O, Haapa K, et al. Helsinki Heart Study: Primary prevention trial with gemfibrocil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Eng J Med 1987; 317: 1237–45
- Telimaa S, Penttilä I, Puolakka J, et al. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis. Fertil Steril 1989; 52: 31–5
- Crona N, Enk L, Samsioe G, et al. High-dose depotmedroxy-progesterone acetate (DMPA) effects on lipid and lipoprotein metabolism. Eur J Obstet Gynecol Reprod Biol; 1983; 97–105
- Luoma P, Sotaniemi E, Pelkonen O. Liver microsomal enzyme induction and serum lipoproteins. Duodecim 1986; 102: 1357–64